应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
UNCY Unicycive Therapeutics, Inc.
盘前交易 03-28 06:25:25 EDT
1.46
+0.01
+0.69%
最高
1.47
最低
1.43
成交量
7.94万
今开
1.43
昨收
1.45
日振幅
2.56%
总市值
5,074万
流通市值
2,006万
总股本
3,475万
成交额
11.46万
换手率
0.58%
流通股本
1,374万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Unicycive Therapeutics Inc盘中异动 急速下跌5.33%
自选股智能写手 · 02-28
Unicycive Therapeutics Inc盘中异动 急速下跌5.33%
Unicycive Therapeutics Inc盘中异动 早盘股价大涨5.73%报0.925美元
自选股智能写手 · 01-29
Unicycive Therapeutics Inc盘中异动 早盘股价大涨5.73%报0.925美元
加载更多
公司概况
公司名称:
Unicycive Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态,直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司,致力于为未满足的医疗条件开发治疗方法。当前,他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立,他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发:UNI 218或Renazorb(用于治疗慢性肾脏病患者的高磷酸盐血症)和UNI 494(用于治疗急性肾脏损伤)。
发行价格:
--
{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":1.46,"timestamp":1711569600000,"preClose":1.45,"halted":0,"volume":79435,"delay":0,"floatShares":13738494,"shares":34754401,"eps":-1.477002,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.01,"latestTime":"03-28 06:25:25 EDT","open":1.43,"high":1.4671,"low":1.43,"amount":114607.2372435,"amplitude":0.025586,"askPrice":1.67,"askSize":200,"bidPrice":1.33,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.477002,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1711632600000},"adr":0,"listingDate":1623988800000,"adjPreClose":1.46,"postHourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.46,"latestTime":"16:57 EDT","volume":480,"amount":695.98,"timestamp":1711573045985},"volumeRatio":0.28906056681449543},"requestUrl":"/m/hq/s/UNCY","defaultTab":"news","newsList":[{"id":"2415320628","title":"Unicycive Therapeutics Inc盘中异动 急速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415320628","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415320628?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:32","pubTimestamp":1709130736,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时32分,Unicycive Therapeutics Inc股票出现波动,股价快速跳水5.33%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.25%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。Unicycive 的另一款药物 UNI-494 是一种新的化学实体,在晚期临床前开发中已获得物质成分专利保护,用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822321687e745ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822321687e745ed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407862764","title":"Unicycive Therapeutics Inc盘中异动 早盘股价大涨5.73%报0.925美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407862764","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407862764?lang=zh_cn&edition=full","pubTime":"2024-01-29 22:30","pubTimestamp":1706538604,"startTime":"0","endTime":"0","summary":"北京时间2024年01月29日22时30分,Unicycive Therapeutics Inc股票出现异动,股价急速拉升5.73%。Unicycive Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Novabay Pharmaceuticals Inc、Rezolute Inc、Unicycive Therapeutics Inc涨幅较大,Revelation Biosciences Inc、Panbela Therapeutics Inc、Novabay Pharmaceuticals Inc较为活跃,换手率分别为589.55%、472.21%、373.06%,振幅较大的相关个股有Processa Pharmaceuticals Inc、Novabay Pharmaceuticals Inc、Zymeworks Inc ,振幅分别为1.09%、0.30%、0.00%。Unicycive Therapeutics Inc公司简介:Unicycive Therapeutics Inc是一家生物技术公司,致力于开发针对某些疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012922300587e6961a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012922300587e6961a&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unicycive.com","stockEarnings":[{"period":"1week","weight":0.0282},{"period":"1month","weight":-0.0759},{"period":"3month","weight":0.6688},{"period":"6month","weight":0.6977},{"period":"1year","weight":-0.1512},{"period":"ytd","weight":0.6826}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0975},{"period":"6month","weight":0.2238},{"period":"1year","weight":0.3225},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Unicycive Therapeutics, Inc.于2016年8月18日在特拉华州注册成立。该公司一直处于休眠状态,直到2017年7月开始评估许可使用的多种药物。他们是一家生物技术公司,致力于为未满足的医疗条件开发治疗方法。当前,他们的两个计划针对有可能提供医疗收益的肾脏疾病。随着公司的发展和团队的建立,他们打算专注于确定肾脏疾病内外的医疗状况。他们目前的开发计划着重于两种新型疗法的开发:UNI 218或Renazorb(用于治疗慢性肾脏病患者的高磷酸盐血症)和UNI 494(用于治疗急性肾脏损伤)。","exchange":"NASDAQ","name":"Unicycive Therapeutics, Inc.","nameEN":"Unicycive Therapeutics, Inc."},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Unicycive Therapeutics, Inc.(UNCY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}